What is the generic name?

DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR

What is the Trade Name for DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR?

Viekira Pak

What are the Indications for DASABUVIR AND OMBITASVIR AND PARITAPREVIR AND RITONAVIR?

• 1 INDICATIONS AND USAGE VIEKIRA PAK is indicated for the treatment of adult patients with chronic hepatitis C virus (HCV) [see Dosage and Administration ( 2.2 ) and Clinical Studies ( 14 )] : genotype 1b without cirrhosis or with compensated cirrhosis genotype 1a without cirrhosis or with compensated cirrhosis for use in combination with ribavirin. VIEKIRA PAK is indicated for the treatment of adult patients with chronic hepatitis C virus (HCV): genotype 1b without cirrhosis or with compensated cirrhosis genotype 1a without cirrhosis or with compensated cirrhosis for use in combination with ribavirin. VIEKIRA PAK includes ombitasvir, a hepatitis C virus NS5A inhibitor, paritaprevir, a hepatitis C virus NS3/4A protease inhibitor, ritonavir, a CYP3A inhibitor and dasabuvir, a hepatitis C virus non-nucleoside NS5B palm polymerase inhibitor. ( 1 )

References: https://open.fda.gov/